loadpatents
Patent applications and USPTO patent grants for Fesharaki; Shahin.The latest application filed is for "immediate release abuse deterrent tablet".
Patent | Date |
---|---|
Oral dosage forms of ibrutinib Grant 11,433,072 - Ghannam , et al. September 6, 2 | 2022-09-06 |
Immediate Release Abuse Deterrent Tablet App 20200078354 - Sareen; Rahul ;   et al. | 2020-03-12 |
Immediate Release Abuse Deterrent Tablet App 20170304297 - Sareen; Rahul ;   et al. | 2017-10-26 |
Modified Release Tranexamic Acid Formulation App 20160287541 - Joshi; Mayank R. ;   et al. | 2016-10-06 |
Modified release tranexamic acid formulation Grant 9,387,178 - Joshi , et al. July 12, 2 | 2016-07-12 |
Immediate Release Abuse Deterrent Tablet App 20150224097 - Sareen; Rahul ;   et al. | 2015-08-13 |
Modified release tranexamic acid formulation Grant 8,597,683 - Joshi , et al. December 3, 2 | 2013-12-03 |
Modified Release Tranexamic Acid Formulation App 20120135079 - Joshi; Mayank R. ;   et al. | 2012-05-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.